The New York-Presbyterian Hospital/Weill Cornell Medical Center is enrolling patients for the research study of an investigational implantable device for the treatment of type-2 diabetes patients who are overweight and do not respond to the prevalent anti-diabetic treatments. The device is placed in the body through a minimally invasive laparoscopic process. The process can be conducted in outpatient settings.